737 related articles for article (PubMed ID: 31601268)
21. Cervical cancer cells suppress effector functions of cytotoxic T cells through the adenosinergic pathway.
Mora-García ML; Ávila-Ibarra LR; García-Rocha R; Weiss-Steider B; Hernández-Montes J; Don-López CA; Gutiérrez-Serrano V; Titla-Vilchis IJ; Fuentes-Castañeda MC; Monroy-Mora A; Jave-Suárez LF; Chacón-Salinas R; Vallejo-Castillo L; Pérez-Tapia SM; Monroy-García A
Cell Immunol; 2017 Oct; 320():46-55. PubMed ID: 28950987
[TBL] [Abstract][Full Text] [Related]
22. MiRNA-340-5p mediates the functional and infiltrative promotion of tumor-infiltrating CD8
Xu Y; Liu Z; Lv L; Li P; Xiu B; Qian W; Liang A
J Exp Clin Cancer Res; 2020 Nov; 39(1):238. PubMed ID: 33168024
[TBL] [Abstract][Full Text] [Related]
23. Involvement of indoleamine 2,3-dioxygenase in impairing tumor-infiltrating CD8 T-cell functions in esophageal squamous cell carcinoma.
Zhang G; Liu WL; Zhang L; Wang JY; Kuang MH; Liu P; Lin YH; Dai SQ; Du J
Clin Dev Immunol; 2011; 2011():384726. PubMed ID: 22013481
[TBL] [Abstract][Full Text] [Related]
24. Anti-PD-1 increases the clonality and activity of tumor infiltrating antigen specific T cells induced by a potent immune therapy consisting of vaccine and metronomic cyclophosphamide.
Weir GM; Hrytsenko O; Quinton T; Berinstein NL; Stanford MM; Mansour M
J Immunother Cancer; 2016; 4():68. PubMed ID: 27777777
[TBL] [Abstract][Full Text] [Related]
25. Local administration of TLR ligands rescues the function of tumor-infiltrating CD8 T cells and enhances the antitumor effect of lentivector immunization.
Xiao H; Peng Y; Hong Y; Huang L; Guo ZS; Bartlett DL; Fu N; Munn DH; Mellor A; He Y
J Immunol; 2013 Jun; 190(11):5866-73. PubMed ID: 23610140
[TBL] [Abstract][Full Text] [Related]
26. Hypoxia-adenosinergic immunosuppression: tumor protection by T regulatory cells and cancerous tissue hypoxia.
Sitkovsky MV; Kjaergaard J; Lukashev D; Ohta A
Clin Cancer Res; 2008 Oct; 14(19):5947-52. PubMed ID: 18829471
[TBL] [Abstract][Full Text] [Related]
27. Immune-Checkpoint Blockade Opposes CD8
Pfannenstiel LW; Diaz-Montero CM; Tian YF; Scharpf J; Ko JS; Gastman BR
Cancer Immunol Res; 2019 Mar; 7(3):510-525. PubMed ID: 30728151
[TBL] [Abstract][Full Text] [Related]
28. The Emerging Role of CD8
Corgnac S; Boutet M; Kfoury M; Naltet C; Mami-Chouaib F
Front Immunol; 2018; 9():1904. PubMed ID: 30158938
[TBL] [Abstract][Full Text] [Related]
29. Tumor derived exosomal ENTPD2 impair CD8
Shi M; Ye L; Zhao L; He L; Chen J; Zhang J; Su Y; Dong H; Liu J; Liang L; Zheng W; Xiao Y; Liu H; Yang X; Yang Z
Cell Commun Signal; 2024 May; 22(1):274. PubMed ID: 38755598
[TBL] [Abstract][Full Text] [Related]
30. The Inhibitory Signaling Receptor Protocadherin-18 Regulates Tumor-Infiltrating CD8
Frey AB
Cancer Immunol Res; 2017 Oct; 5(10):920-928. PubMed ID: 28874354
[TBL] [Abstract][Full Text] [Related]
31. Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study.
Romagnoli G; Wiedermann M; Hübner F; Wenners A; Mathiak M; Röcken C; Maass N; Klapper W; Alkatout I
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885584
[TBL] [Abstract][Full Text] [Related]
32. B7-H4 reduces the infiltration of CD8+T cells and induces their anti-tumor dysfunction in gliomas.
Qi Y; Hu L; Ji C; Yang X; Yao J; Chen D; Yao Y
Neoplasia; 2024 Aug; 54():101007. PubMed ID: 38796932
[TBL] [Abstract][Full Text] [Related]
33. PGE
Lacher SB; Dörr J; de Almeida GP; Hönninger J; Bayerl F; Hirschberger A; Pedde AM; Meiser P; Ramsauer L; Rudolph TJ; Spranger N; Morotti M; Grimm AJ; Jarosch S; Oner A; Gregor L; Lesch S; Michaelides S; Fertig L; Briukhovetska D; Majed L; Stock S; Busch DH; Buchholz VR; Knolle PA; Zehn D; Dangaj Laniti D; Kobold S; Böttcher JP
Nature; 2024 May; 629(8011):417-425. PubMed ID: 38658748
[TBL] [Abstract][Full Text] [Related]
34. Receptor desensitization and blockade of the suppressive effects of prostaglandin E(2) and adenosine on the cytotoxic activity of human melanoma-infiltrating T lymphocytes.
Su Y; Jackson EK; Gorelik E
Cancer Immunol Immunother; 2011 Jan; 60(1):111-22. PubMed ID: 20960188
[TBL] [Abstract][Full Text] [Related]
35. Chronic Adrenergic Stress Contributes to Metabolic Dysfunction and an Exhausted Phenotype in T Cells in the Tumor Microenvironment.
Qiao G; Chen M; Mohammadpour H; MacDonald CR; Bucsek MJ; Hylander BL; Barbi JJ; Repasky EA
Cancer Immunol Res; 2021 Jun; 9(6):651-664. PubMed ID: 33762351
[TBL] [Abstract][Full Text] [Related]
36. Myeloid expression of adenosine A2A receptor suppresses T and NK cell responses in the solid tumor microenvironment.
Cekic C; Day YJ; Sag D; Linden J
Cancer Res; 2014 Dec; 74(24):7250-9. PubMed ID: 25377469
[TBL] [Abstract][Full Text] [Related]
37. SOD3 induces a HIF-2α-dependent program in endothelial cells that provides a selective signal for tumor infiltration by T cells.
Carmona-Rodríguez L; Martínez-Rey D; Fernández-Aceñero MJ; González-Martín A; Paz-Cabezas M; Rodríguez-Rodríguez N; Pérez-Villamil B; Sáez ME; Díaz-Rubio E; Mira E; Mañes S
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32591431
[TBL] [Abstract][Full Text] [Related]
38. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
[TBL] [Abstract][Full Text] [Related]
39. Concomitant blockade of A2AR and CTLA-4 by siRNA-loaded polyethylene glycol-chitosan-alginate nanoparticles synergistically enhances antitumor T-cell responses.
Ghasemi-Chaleshtari M; Kiaie SH; Irandoust M; Karami H; Nabi Afjadi M; Ghani S; Aghaei Vanda N; Ghaderi Sede MJ; Ahmadi A; Masjedi A; Hassannia H; Atyabi F; Hojjat-Farsangi M; Namdar A; Ghalamfarsa G; Jadidi-Niaragh F
J Cell Physiol; 2020 Dec; 235(12):10068-10080. PubMed ID: 32488862
[TBL] [Abstract][Full Text] [Related]
40. Natural killer group 2D and CD28 receptors differentially activate mammalian/mechanistic target of rapamycin to alter murine effector CD8+ T-cell differentiation.
McQueen B; Trace K; Whitman E; Bedsworth T; Barber A
Immunology; 2016 Mar; 147(3):305-20. PubMed ID: 26661515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
